![Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 on X: "ADA 2022 standards of care is out. With a set of more than 300 powerpoint slides @AliceYYCheng @AmarPut @SABOURETCardio @drpablocorral @nicolasrennamd @HanCardiomd @DrMarthaGulati @ Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 on X: "ADA 2022 standards of care is out. With a set of more than 300 powerpoint slides @AliceYYCheng @AmarPut @SABOURETCardio @drpablocorral @nicolasrennamd @HanCardiomd @DrMarthaGulati @](https://pbs.twimg.com/media/FHJWPuEXMAIuUt7.jpg:large)
Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 on X: "ADA 2022 standards of care is out. With a set of more than 300 powerpoint slides @AliceYYCheng @AmarPut @SABOURETCardio @drpablocorral @nicolasrennamd @HanCardiomd @DrMarthaGulati @
![Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00125-022-05787-2/MediaObjects/125_2022_5787_Fig3_HTML.png)
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia
![Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00125-022-05787-2/MediaObjects/125_2022_5787_Fig4_HTML.png)
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia
![New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia](https://diabetologia-journal.org/wp-content/uploads/2018/09/Fig-2-for-EASD-ADA.jpg)
New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia
American Diabetes Association - Professional Publications - ADA's "Standards of Medical Care in Diabetes—2022" is finally here! Featuring American Diabetes Association's latest clinical practice recommendations, the global standard for diabetes care ...
![ADA/EASD consensus update on management of hyperglycaemia in type 2 diabetes – report published in Diabetologia and Diabetes Care – Diabetologia ADA/EASD consensus update on management of hyperglycaemia in type 2 diabetes – report published in Diabetologia and Diabetes Care – Diabetologia](https://diabetologia-journal.org/wp-content/uploads/2022/09/Screenshot-2022-09-21-at-13.20.37.png)
ADA/EASD consensus update on management of hyperglycaemia in type 2 diabetes – report published in Diabetologia and Diabetes Care – Diabetologia
![ADA Releases 2022 Standards of Medical Care in Diabetes-Knowledge Center-Lansion Biotechnology Co., Ltd. ADA Releases 2022 Standards of Medical Care in Diabetes-Knowledge Center-Lansion Biotechnology Co., Ltd.](http://en.lansionbio.com/uploads/2021/12/270939018651.jpg)
ADA Releases 2022 Standards of Medical Care in Diabetes-Knowledge Center-Lansion Biotechnology Co., Ltd.
![Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00125-022-05787-2/MediaObjects/125_2022_5787_Fig1_HTML.png)
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia
![Sergio Zúñiga on X: "🔥 Criterios diagnósticos en PRE-Diabetes - ADA 2022. *Actualización. Diabetes Care 2022;45(Suppl. 1):S17–S38 ___ https://t.co/2zPHOMBECU https://t.co/i56xxodthN" / X Sergio Zúñiga on X: "🔥 Criterios diagnósticos en PRE-Diabetes - ADA 2022. *Actualización. Diabetes Care 2022;45(Suppl. 1):S17–S38 ___ https://t.co/2zPHOMBECU https://t.co/i56xxodthN" / X](https://pbs.twimg.com/media/FHKcZBLXoAMxcid.jpg)